Front Row Advisors’s Integra LifeSciences IART Stock Holding History

Front Row Advisors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-84	Closed	-$2.45K	–	666
2024 Q2	$2.45K	Hold	84	–	–	﹤0.01%	834
2024 Q1	$2.98K	Buy	+84	New	+$3.36K	﹤0.01%	798
2023 Q4	–	Sell	-84	Closed	-$3.21K	–	630
2023 Q3	$3.21K	Hold	84	–	–	﹤0.01%	753
2023 Q2	$3K	Hold	84	–	–	﹤0.01%	753
2023 Q1	$5K	Hold	84	–	–	﹤0.01%	670
2022 Q4	$5K	Hold	84	–	–	﹤0.01%	638
2022 Q3	$4K	Hold	84	–	–	﹤0.01%	696
2022 Q2	$5K	Hold	84	–	–	﹤0.01%	672
2022 Q1	$5K	Hold	84	–	–	﹤0.01%	722
2021 Q4	$6K	Hold	84	–	–	﹤0.01%	697
2021 Q3	$6K	Hold	84	–	–	﹤0.01%	695
2021 Q2	$6K	Hold	84	–	–	﹤0.01%	692
2021 Q1	$6K	Hold	84	–	–	﹤0.01%	679
2020 Q4	$5K	Hold	84	–	–	﹤0.01%	684
2020 Q3	$5K	Hold	84	–	–	﹤0.01%	683
2020 Q2	$4K	Hold	84	–	–	﹤0.01%	690
2020 Q1	$4K	Hold	84	–	–	﹤0.01%	663
2019 Q4	$5K	Hold	84	–	–	﹤0.01%	613
2019 Q3	$5K	Hold	84	–	–	﹤0.01%	593
2019 Q2	$5K	Hold	84	–	–	﹤0.01%	577
2019 Q1	$5K	Hold	84	–	–	﹤0.01%	582
2018 Q4	$4K	Hold	84	–	–	﹤0.01%	592
2018 Q3	$5	Hold	84	–	–	﹤0.01%	557
2018 Q2	$5	Hold	84	–	–	﹤0.01%	591
2018 Q1	$5K	Hold	84	–	–	﹤0.01%	563
2017 Q4	$4K	Buy	+84	New	+$4.11K	﹤0.01%	566

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Front Row Advisors's IART Position: Q3 2024 in Review

Front Row Advisors sold out of Integra LifeSciences (IART) in Q3 2024, closing a stake of 84 shares — an estimated $2.45K sold.

Front Row Advisors first reported a position in IART in Q4 2017 and held it in 26 quarters. The position peaked at $6K in Q4 2021. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.

Front Row Advisors reported no remaining Integra LifeSciences position as of Q3 2024 after selling out during the quarter.
Front Row Advisors sold 84 Integra LifeSciences shares in Q3 2024, an estimated $2.45K.
Front Row Advisors first reported a position in Integra LifeSciences in Q4 2017 and held it in 26 quarters.
Front Row Advisors's Integra LifeSciences position peaked at $6K in Q4 2021.
225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.